Liver involvement in hereditary hemorrhagic telangiectasia
- 249 Downloads
Liver vascular malformations (VMs) in hereditary hemorrhagic telangiectasia (HHT) are typically diffuse and can evolve from small telangiectasias to large arteriovenous malformations, with various stages of severity. Doppler US is the ideal first-line investigation for the assessment of liver VMs in HHT due to its safety, tolerability, low costs, and accuracy for the detection of liver VMs. The caliber, course, and flow characteristics in the hepatic artery, portal vein, and hepatic vein as determined by Doppler US, together with parenchymal abnormalities, support the diagnosis of liver VMs in HHT and their severity staging. When Doppler US expertise is lacking or an assessment of HHT patients with symptoms/signs suggestive of complicated liver VMs is required, particularly if OLT is considered, multiphase CT or MRI is suitable to investigate symptomatic liver VMs. Liver biopsy is neither necessary for the diagnosis of hepatic VMs related to HHT nor should be considered in HHT patients with liver mass/es suggestive of focal nodular hyperplasia.
KeywordsHereditary hemorrhagic telangiectasia Vascular malformations Liver Doppler US Computed tomography Magnetic resonance imaging
Compliance with ethical standards
This study was not funded by any grant or financial support.
Conflict of interest
Author Elisabetta Buscarini declares that she has no conflict of interest. Author Silvia Gandolfi declares that she has no conflict of interest. Author Saverio Alicante declares that he has no conflict of interest. Author Claudio Londoni declares that he has no conflict of interest. Author Guido Manfredi declares that he has no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 20.Buscarini E, Danesino C, Plauchu H, et al. (2004) High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 30:1089–1097. https://doi.org/10.1016/j.ultrasmedbio.2004.08.004 CrossRefPubMedGoogle Scholar
- 23.Lerut J, Orlando G, Adam R, et al. (2006) Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg 244:854–862. https://doi.org/10.1097/01.sla.0000247258.35406.a4 CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Buscarini E, Gebel M, Ocran K, et al. (2008) Interobserver agreement in diagnosing liver involvement in hereditary hemorrhagic telangiectasia by Doppler ultrasound. Ultrasound Med Biol 34:718–725. https://doi.org/10.1016/j.ultrasmedbio.2007.11.007 CrossRefPubMedGoogle Scholar
- 34.Brancatelli G, Federle MP, Grazioli L, et al. (2002) Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 178:877–883. https://doi.org/10.2214/ajr.178.4.1780877 CrossRefPubMedGoogle Scholar